Not available
Quote | Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)
Last: | $8.82 |
---|---|
Change Percent: | 0.77% |
Open: | $8.99 |
Close: | $8.82 |
High: | $9.125 |
Low: | $8.675 |
Volume: | 2,398,300 |
Last Trade Date Time: | 12/04/2023 03:00:00 am |
News | Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)
2023-11-23 02:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-11-21 10:30:55 ET Aurinia Pharmaceuticals ( NASDAQ: AUPH ) soared 6.7% amid takeover speculation. The Aurinia ( AUPH ) stock surge comes amid a report that a Gilead Sciences ( GILD ) corporate jet made a trip to Aurinia's headquarters in Edmonton, Canada, accord...
Message Board Posts | Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)
Subject | By | Source | When |
---|---|---|---|
Ha! | Ganz | investorshub | 04/30/2023 4:23:08 PM |
I did the same and I have a | kipster210 | investorshub | 04/29/2023 9:45:03 PM |
Just voted NO on everything management wants and | Benny450 | investorshub | 04/29/2023 8:49:52 PM |
They probably tallying up the votes and it | Cosa | investorshub | 04/28/2023 10:21:53 PM |
I would never touch that shitplaying right into | greggors | investorshub | 04/28/2023 9:55:27 PM |
News, Short Squeeze, Breakout and More Instantly...
Aurinia Pharmaceuticals Inc Company Name:
AUPH Stock Symbol:
NASDAQ Market:
Aurinia Pharmaceuticals Inc Website:
2023-11-23 02:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares are trading higher, adding to gains of more than 17% over the last week. The stock has been trend...
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that the Company’s collaboration partner, Otsuka Pharmaceutical Ltd., filed a new drug application (NDA) for voclosporin for the treatment of lupus nephritis (LN) with the Japanese Ministry of Health, Labo...